Marinus Pharmaceuticals Inc. (61Y)
Market Open
18 Aug, 06:06
XFRA 
NASDAQ (NMS) Primary XFRA €
0. 30
-0.02
-7.5%
€
- Market Cap
- P/E Ratio
- Div Yield
1,957 Volume
-2.53 Eps
€ 0.32
Previous Close Want to track 61Y and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
61Y Earnings Reports FAQ
What is the earnings per share (EPS) for 61Y?
The current EPS is -2.53.
What is the company's earnings growth rate?
Marinus Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Marinus Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Marinus Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 61Y at this time, as Marinus Pharmaceuticals Inc has no recent EPS data to calculate it.
